ROCKWELL MEDICAL, INC. (RMTI) Return on equity 2017–2025
ROCKWELL MEDICAL, INC. (RMTI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-14.4%FY2025 · since FY2017: -78.8% → -14.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14.4% | -12.9 pp |
| FY2024 | -1.5% | +38.2 pp |
| FY2023 | -39.6% | +92.8 pp |
| FY2022 | -132.4% | +1156.5 pp |
| FY2021 | -1288.9% | -1198.5 pp |
| FY2020 | -90.4% | +77.6 pp |
| FY2019 | -168.0% | -50.2 pp |
| FY2018 | -117.8% | -39.0 pp |
| FY2017 | -78.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RMTI financial trends
RMTI RevenueRMTI Net incomeRMTI Net marginRMTI Gross profitRMTI Gross marginRMTI Operating incomeRMTI Operating marginRMTI Operating cash flowRMTI Free cash flowRMTI Capital expendituresRMTI Stock buybacksRMTI Dividends paidRMTI Total assetsRMTI Total liabilitiesRMTI Shareholders’ equityRMTI overview →